News
Discovered a new strategy to fight the metastatic melanoma
It has shown that the combination of chemotherapy with a BRAF oncogene inhibitor effectively treats this disease. This alternative opens the door to offer a new approach to patients affected by this type of tumor, which does not have a curative treatment in the more advanced stages or those with relapse.
The impact of obesity is becoming increasingly important in kidney transplantation
A study by the Nephrology and Renal Transplantation research group of IDIBELL and the Bellvitge University Hospital (HUB) highlights the need to raise awareness among both transplant candidates and potential donors
A new study defines an epigenetic predisposition to suffer leukemia or lymphoma induced by the infection of the HTLV-1 virus
A study, with the participation of IDIBELL and ICO, published in Molecular Cancer, has described that people with epigenetic alterations in the FHIT tumor suppressor gene are more predisposed to developing the disease.
The pandemic has aggravated the symptoms of almost a third of patients with Obsessive-Compulsive Disorder (OCD)
A study led by IDIBELL and the Hospital de Bellvitge shows that during the lockdown, suicide thoughts were more frequent among people with OCD
Identified an early neuronal dysfunction in Parkinson’s that could help early diagnosis
Researchers from IDIBELL and the University of Barcelona (UB) have described that neurons derived from Parkinson’s patients show impairments in their transmission before neurodegeneration.
A nursing intervention increases the adherence to treatment after a heart attack in elderly patients
A study led by nursing professionals from the Bellvitge University Hospital and IDIBELL has shown that a specific nursing intervention achieves more adherence to treatment in complex elderly patients who have suffered a myocardial infarction.
Diets that promote inflammation can increase the risk of breast cancer by up to 12%
Research carried out by IDIBELL and ICO within the framework of the European EPIC study, which includes the monitoring of more than 350,000 women for 15 years, has determined the inflammatory potential of their diets with a new scoring system.
Two IDIBELL researchers receive support from the Mutua Madrileña Foundation
The Mutua Madrileña Foundation today gave its XVII Grants for Health Research to 27 research projects throughout Spain, 5 of them in Catalonia, of which 2 have been awarded to IDIBELL researchers.
Researchers from IDIBELL and Bellvitge University Hospital develop a new algorithm to predict sudden death and potentially lethal arrhythmias in some heart patients
Thanks to this new tool, it will be possible to determine more precisely the indication for an implantable defibrillator for high-risk patients